| HOME >> BIOLOGY >> TECHNOLOGY |
LOD, Israel, October 18 /PRNewswire/ -- Glycominds Ltd., a biodiagnostics company specializing in glycan biomarkers for diagnosis and disease management of autoimmune diseases and cancer, announced today the appointment of Dr. Chen Even as Chairman of the Company's board of directors. Dr. Chen, a board member since 2004, contributes more than a decade of experience in in-vitro diagnostics.
"We are very pleased to elevate Dr. Even to the role of Chairman," stated Dr. Avinoam Dukler, Glycominds' co-founder, director and Chief Executive Officer. "As a valuable member of our team, his in-depth experience in in-vitro diagnostics has heightened the credibility of Glycominds and our glycan technology as we roll-out our innovative tests for autoimmune prognosis and the early detection of cancer in Israel, Europe, and the U.S. In addition to his strong scientific educational background, he raises our Company's profile in preparation for an initial public offering in the U.S."
Dr. Even is a board member and Senior Corporate Vice President of
Commercial Operations at DiaSorin, where he participated in management
buyout in 2000. The Italy-based developer and manufacturer of reagents for
in-vitro diagnostics markets its products world-wide in the fields of
infectious disease, hepatitis, endocrinology, bone and mineral metabolism,
cancer, brain injury, cardiac disorders, therapeutic drug monitoring and
autoimmunity. In recent years Dr. Even has been responsible for executing
DiaSorin's growth and acquisition strategies. Prior to DiaSorin, Dr. Even
was a Director of Molecular Biology and Director of Worldwide Distribution
for the medical division of American Standard International. He has a Ph.D.
in microbiology/virology and a bachelor's degree in computer science from
the University of Minnesota, and completed his fellowship in neurology at
the University of California. He has also been awarded several grants and
published over twenty publications in peer-revie
'/>"/>
| SOURCE Glycominds Ltd. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |